Skip to main content
logo
AstraZeneca Pharma India Limited (BOM:506820)
India flag India · Delayed Price · Currency is INR
6,387.90
+93.00 (1.48%)
At close: Nov 6, 2026

AstraZeneca Pharma India Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
159,698193,986215,159133,01081,18363,886
Market Cap Growth
-33.37%-9.84%61.76%63.84%27.07%-15.11%
Enterprise Value
154,908190,335210,362127,86176,55260,484
Last Close Price
6387.907724.928538.845260.873197.332509.29

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
89.86103.45185.9082.3581.76103.71
PS Ratio
6.128.5312.5410.278.097.93
PB Ratio
18.1722.2327.9318.6813.7912.49
P/TBV Ratio
18.1722.2327.9518.7413.7912.49
P/FCF Ratio
60.01-338.25777.38163.1270.07
P/OCF Ratio
56.44-329.19477.25139.2763.38

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
5.948.3612.269.877.637.51
EV/EBITDA Ratio
63.0275.9384.6769.8147.4573.16
EV/EBIT Ratio
65.2481.4397.9374.5851.4387.20
EV/FCF Ratio
58.21-330.71747.29153.8166.33

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.110.130.050.010.010.02
Debt / EBITDA Ratio
0.390.420.140.020.040.10
Debt / FCF Ratio
0.36-0.560.270.140.10
Net Debt / Equity Ratio
-0.55-0.39-0.65-0.70-0.84-0.86
Net Debt / EBITDA Ratio
-1.95-1.34-2.01-2.73-3.06-5.32
Net Debt / FCF Ratio
-1.8020.18-7.87-29.28-9.91-4.82
Asset Turnover
1.371.301.321.261.090.99
Inventory Turnover
1.861.762.502.872.222.11
Quick Ratio
0.720.681.051.891.611.64
Current Ratio
1.631.771.912.612.182.12
Return on Equity (ROE)
21.19%22.82%15.62%24.84%18.05%12.73%
Return on Assets (ROA)
7.80%8.33%10.34%10.39%10.11%5.32%
Return on Invested Capital (ROIC)
36.98%43.14%66.13%82.29%131.87%54.86%
Return on Capital Employed (ROCE)
23.70%23.20%26.40%23.80%24.80%13.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
1.11%0.97%0.54%1.21%1.22%0.96%
FCF Yield
1.67%-0.09%0.30%0.13%0.61%1.43%
Dividend Yield
0.56%0.46%0.37%0.45%0.49%0.39%
Payout Ratio
50.64%42.66%51.84%24.77%20.14%8.12%
Total Shareholder Return
0.53%0.46%0.37%0.45%0.49%0.39%